Cardiology Self-Assessment Program (CardSAP) Book 2: Blood Pressure Disorders and Practice Management (Cert # L239232)

The target audience for Cardiology Self-Assessment Program (CardSAP) Book 2: Blood Pressure Disorders and Practice Management is board-certified cardiology pharmacists caring for patients with cardiovascular diseases being treated within a cardiac intensive care setting or undergoing cardiovascular surgical procedures.

Board certified pharmacists are eligible to receive up to 15 contact hours of recertification credit for completing this course. To earn recertification credit, learners must review the activity content and successfully complete the online assessments by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.

Blood Pressure Disorders and Practice Management I
ACPE #: 0217-9999-23-208-H01-P
Chapter: Management of Hypertension

• Analyze the effect of pharmacist integration into team and value-based care models.
• Justify the multifaceted role of the pharmacist in hypertension management.
• Evaluate the type and impact of pharmacist-driven interventions on blood pressure management and outcomes across various practice settings.
• Based on pragmatic factors, design a pharmacist-based hypertension intervention for patients with uncontrolled hypertension. 

Chapter: Hypertension in Special Populations

• Analyze patient medical history to assess risk factors for developing hypertension.
• Determine blood pressure goals for select patient populations.
• Apply knowledge of drug and disease-state concepts for select patient populations to manage hypertension.
• Evaluate pharmacotherapy options for select patient populations with hypertension based on evidence-based guidelines. 

Blood Pressure Disorders and Practice Management II
ACPE #: 0217-9999-23-209-H01-P
Chapter: Syncope and Orthostatic Hypotension

• Evaluate patients for the underlying pathophysiology of orthostatic hypotension (OH) and classify OH by the predominant features.
• Develop appropriate nonpharmacologic and pharmacologic therapy plans for the treatment of OH, vasovagal syncope, postural orthostatic tachycardia syndrome, and inappropriate sinus tachycardia.
• Justify appropriate drug selection for the treatment of OH according to concomitant conditions and compelling indications.
• Design an evidence-based pharmacologic treatment strategy for OH to achieve improvement in OH symptoms according to clinical practice guidelines. 

Chapter: Secondary Hypertension

• Distinguish between potential pharmacologic and nonpharmacologic causes of secondary hypertension.
• Assess patient-specific factors to determine the need to screen patients for secondary hypertension.
• Develop appropriate screening modalities for suspected causes of secondary hypertension.
• Design treatment regimens for patients with identified causes of secondary hypertension. 

Blood Pressure Disorders and Practice Management III
ACPE #: 0217-9999-23-210-H01-P
Chapter: Telehealth and Non-Traditional Health Care Delivery in Cardiology

• Distinguish the differences between telehealth services used in both traditional and nontraditional health care delivery models.
• Assess the advantages and disadvantages of using telehealth services in practice.
• Justify the use of telehealth services in nontraditional health care delivery models.
• Evaluate pharmacy services within a nontraditional health care delivery model using telehealth.
• Perform pharmacist-led telehealth services within a nontraditional health care delivery model. 

Chapter: Cancer Therapy–Related Cardiovascular Toxicity

• Evaluate patients for the most common cancer therapy-related cardiovascular toxicities (CTR-CVT).
• Estimate cardiovascular risk at baseline and during survivorship period.
• Develop a plan for the mitigation of CTR-CVT risk.
• Develop a plan that incorporates diagnosis, monitoring, when to withhold cancer therapy, and managing CTR-CVT.
• Devise management plans for other cardiovascular events and/or CTR-CVT during or after cancer therapy. 

Blood Pressure Disorders and Practice Management IV
ACPE #: 0217-9999-23-211-H01-P
Interactive Case: Blood Pressure Measurement

• Demonstrate proper blood pressure measurement technique using a conventional office method.
• Evaluate the utility of home blood pressure monitoring (HBPM) in the diagnosis of hypertension and assessment of blood pressure.
• Apply 24-hour Ambulatory Blood Pressure Monitoring (ABPM) to detect underlying blood pressure abnormalities.
• Assess the role for automated office blood pressure (AOBP) monitoring as an alternative blood pressure measuring strategy to traditional approaches. 

Recorded Webcast: Motivational Interviewing for Adherence

• Assess patient readiness for change and apply interventions that support patient change.
• Justify the use of motivational interviewing in communicating with patients.
• Use motivational interviewing skills when communicating with patients.
• Evaluate the impact of motivational interviewing on medication adherence and behavior change.

Faculty Information

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

The following persons in control of this activity’s content have relevant financial relationships: 

• Consultancies: Anastasia Armbruster (ACC/AHA); William L. Baker (Bayer); Katherine E. Di Palo (Vifor CSL); Heather Moore (Novartis, Lilly, Pfizer); Tien Ng (Synchrony Medical Communications); Elizabeth Pogge (Sanofi); Cynthia Jackevicius (AHA, CSHP); Herb Patterson (SQ Innovations)

• Honoraria: Brandon E. Cave (AstraZeneca); Elizabeth Pogge (ASCP; APhA; ASHP); Jo Ellen Rodgers (Impact Education)

• Grants: William L. Baker (AstraZeneca); Katherine E. Di Palo (Vifor CSL); Jo Ellen Rodgers (NIH [multiple grants], U.S. FDA); Cynthia Jackevicius (Heart and Stroke Foundation of Canada)

All other persons in control of content do not have any relevant financial relationships with an ineligible company. 

As required by the Standards of Integrity and Independence in Accredited Continuing Education, all relevant financial relationships have been mitigated prior to the CPE activity.

Activities consist of educational materials, assessments, and activity evaluations. In order to receive continuing pharmacy education credit, learners must:

• Complete the attestation statement
• Review all content
• Complete and pass the assessments
• Complete the evaluations 

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.